Caroline Stone
Call Host
Replay available
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) Q2 2021 earnings conference call, held 2021-08-05. Replay captured from the company's public earnings webcast.

Call Host
Executive Chairman and Co-CEO
Chief Financial Officer
Chief Operating Officer and Chief Technology Officer
Good day, ladies and gentlemen, and welcome to the Apollo Medical Holdings second quarter 2021 financial results call. All lines have been placed on a listen only mode and the floor will be open for questions and comments following the presentation. If you would like to enter the queue for questions, please hit star one on your telephone keypad. At this time, it is my pleasure to turn the floor over to your host, Caroline Stone. Ma'am, the floor is yours. Thank you, Operator, and hello, everyone. Thank you for joining us. The press release announcing Apollo Medical Holdings, Inc.' 's results for the second quarter ended June 30, 2021, is available at the Investors section of the company's website at www.apollomed.net. To provide some additional background on its results, the company has made a supplemental deck available on its website. A replay of this broadcast will also be made available at Apollo Med's website after the conclusion of this call. Before we get started, I would like to remind everyone that this conference call and any accompanying information discussed herein contains certain forward-looking statements within the meaning of the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terms such as anticipate, believe, expect, future, plan, outlook, and will, and include, among other things, statements regarding the company's guidance for the year ending December 31st, 2021. continued growth acquisition strategy, ability to deliver sustainable long-term value, ability to respond to the changing environment, operational focus, strategic growth plans, and merger integration efforts, as well as the impact of the 2020 novel coronavirus or COVID-19 pandemic and the Delta variant o...